ADCYAP1 and Parkinson disease: Similar to earlier results, we also found decreased PACAP levels in PD patients without DBS treatment, and we provide here the first evidence for a significant increase of PACAP level in DBS-treated patients supporting the hypothesis that PACAP could have a potent neuroprotective property in this disease.